Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07756515

Conditions

Informed Consent

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CoCo Chatbot

Study Details

Brief summary:

The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.

Conditions

Informed Consent

Study ID

NCT07756515

Start date

Sep 11, 2026

Status verified date

Oct, 2026

Completion date

Dec 17, 2031

Anticipated

Primary completion date

Dec 17, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ability to understand and willingness to provide informed consent.
  • Age ≥18 years.
  • Patients whose preferred language is English.
  • Patients who are being considered for enrollment in selected clinical research studies.

Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study.

Exclusion Criteria:

N/A

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Phase I Feasibility Cohort: Remote IC Process for Non-Therapeutic Studies

All participants will be provided with an abbreviated informed consent form describing this study and providing sufficient information for patients to make an informed decision regarding participation.

Interventions

CoCo Chatbot

A patient-facing chatbot designed to obtain informed consent

Primary outcome measure

  • Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Funda Meric-Bernstam, MD

(713) 794-1226fmeric@mdanderson.org

Locations

UT MD Anderson

Recruiting

Houston, Texas, United States, 77030

Contacts

Funda Meric-Bernstam, MD

713-794-1226fmeric@mdanderson.org

Principal Investigator:

Funda Meric-Bernstam, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Oct 26, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-27. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-10-26. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.